Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Feb 18;58(1):2262.
doi: 10.4081/ejh.2014.2262.

MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells

Affiliations
Clinical Trial

MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells

J Zhang et al. Eur J Histochem. .

Erratum in

Abstract

Matrix metalloproteinases (MMPs) have been implicated in a variety of pathophysiological conditions, of which MMP-7 is expressed by tumor cells of epithelial and mesenchymal origin. However, the function of MMP-7 in human lung adenocarcinoma (LAC) is unclear. In the present study the expression of MMP-7 in LAC was examined by immunohistochemical assay using a tissue microarray procedure. A loss-of-function experiment was performed to explore the effects and molecular mechanisms of lentiviral vector-mediated MMP-7 siRNA (siMMP-7) on cell proliferation and invasive potential in LAC A549 cells, measured by MTT and Transwell assays, respectively. It was found that, the expression of MMP-7 protein in LAC was significantly increased compared with that in adjacent non-cancerous tissues (ANCT) (76.0% vs 44.0%, P<0.001), and positively correlated with lymph node metastases of the tumor (P=0.014). Furthermore, targeted inhibition of cyclooxygenase-2 (COX-2) by siRNA downregulated the expression of MMP-7 and inhibited invasion of LAC cells, and knockdown of MMP-7 suppressed tumor proliferation and invasion in LAC cells. Taken together, our findings indicate that increased expression of MMP-7 is associated with lymph node metastasis and upregulated by COX-2, and promotes the tumorigenesis of LAC, suggesting that MMP-7 may be a potential therapeutic target for the treatment of cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosure: no conflict of interest to disclose.

Figures

Figure 1.
Figure 1.
The expression of MMP-7 protein in LAC tissues (magnification: 200×). LAC tissues were immunohistochemically stained with an anti-MMP-7 and COX-2 antibodies and classified as positive expression (A) and negative expression (C). Adjacent non-cancer tissues were immunohistochemically stained with an anti-MMP-7 antibody and classified as positive expression (B) and negative expression (D). COX-2 was highly expressed in LAC tissues (E) and lowly expressed in ANCT (F). Positive immunostaining of MMP-7 and COX-2 was mainly localized in the cytoplasm of tumor and tissue cells. Scale bars: A-C, E,F) 75 µm; D) 150 µm.
Figure 2.
Figure 2.
The effect of COX-2 on the expression of MMP-7. After LAC A549 cells were transfected with siCOX-2 adenovirus for 24 h, the expression levels of COX-2 and MMP-7 were detected by Real-time PCR (A, B) and Western blot assays (C-F). The expression of COX-2 and MMP-7 was significantly decreased in siCOX-2 group compared with the CON and NC groups (each **P<0.01), suggesting that COX-2 might upregulate the expression of MMP-7 in LAC cells.
Figure 3.
Figure 3.
The effect of COX-2 knockdown on cell invasion. A,B) Transwell assay was used to determine cell invasion; cell invasive potential was markedly inhibited in siCOX-2 group compared with the CON and NC groups (**P<0.01), suggesting that targeted inhibition of COX-2 might block invasion of LAC cells. Scale bars: A) 75 µm.
Figure 4.
Figure 4.
Knockdown of MMP-7 expression in LAC A549 cells. After LAC A549 cells were transfected with siMMP-7 lentivirus for 24 h, the expression level of MMP-7 was detected by real-time PCR (A) and Western blot assays (B,C), indicating that the expression of MMP-7 could be knocked down in siMMP-7 group compared with CON and NC groups (**P<0.01).
Figure 5.
Figure 5.
The effect of MMP-7 knockdown on cell proliferation. A) MTT assay was used to evaluate cell proliferative activity for consecutive 3 days; cell proliferative activity was remarkably diminished in a time-dependent manner in siMMP-7 group compared with the CON and NC groups (**P<0.01). B) [3H] thymi-dine incorporation into DNA was assessed by scintillation counting. Results are expressed as percentage of increase of [3H] thymi-dine incorporation in serum-stimulated cells over that of quiescent cells for each cell population, indicating that the increase of [3H]dT incorporation induced by serum was higher in CON and NC groups than in siMMP-7 group (**P<0.01). C,D) The expression level of PCNA protein, examined by Western blot assay, was downregulated in siMMP-7 group compared with the CON and NC groups (**P<0.01), suggesting that knockdown of MMP-7 might inhibit proliferation of LAC cells through downregulation of PCNA expression.
Figure 6.
Figure 6.
The effect of MMP-7 knockdown on cell invasion. A,B) Transwell assay was performed to determine cell invasion; cell invasive potential was markedly weakened in siMMP-7 group compared with the CON and NC groups (**P<0.01), suggesting that knockdown of MMP-7 might inhibit invasion of LAC cells. Scale bar: A) 75 µm.

Similar articles

Cited by

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30 - PubMed
    1. William WN, Jr, Glisson BS. Novel strategies for the treatment of small-cell lung carcinoma. Nat Rev Clin Oncol 2011;8:611-9 - PubMed
    1. Tajima Y, Yamazaki K, Makino R, Nishino N, Aoki S, Kato M, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006;12:6469-79 - PubMed
    1. Leinonen T, Pirinen R, Böhm J, Johansson R, Ropponen K, Kosma VM. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinico-pathological factors, betacatenin and prognosis. Lung Cancer 2006;51:313-21 - PubMed
    1. Kren L, Goncharuk VN, Krenová Z, Stratil D, Hermanová M, Skricková J, et al. Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies. Cesk Patol 2006;42:16-9 - PubMed

Publication types

MeSH terms